Abel Hernández
Director General
Yoloxóchitl Macías
Yoloxóchitl Macías
Chief of Health Area
View from the Top

Tech Advantages Make Health Industry Highly Attractive

Wed, 09/06/2017 - 11:03

Q: What percentage of ANCE’s activities is in the health sector? Which segment offers the greatest potential?

AH: We are mainly focused on security and risk management but our key operations are in electro-technology, which accounts for about 60 percent of our activities, while a bit over 35 percent is in rational use of environmental resources and 2.73 percent is in the food and the health sectors. We entered the health industry with expertise on intelligent regulation. The state must regulate the liberties of economic players – the possibilities for producers and the needs of consumers – in order to improve the quality of life of its citizens. Mexico is a big consumer of health products like medical devices and drugs. ANCE is betting on medicines because the growth of the health industry is highly attractive in terms of technological development. Moreover, Mexico’s quality of life is improving and the country is among the most attractive regarding its economic and social growth potential.

Q: Of the services ANCE offers, which attract the most demand?

YM: ANCE is an authorized third-party. Medical devices represent the largest segment of our health market, about 80 percent of applications we receive. The most in-demand service is sanitary registration of innovative technologies.

Q: What benefits can ANCE offer its clients that other authorized third-parties cannot?

AH: We focus on differentiating ourselves from our competitors through high-multidisciplinary expertise, as multidisciplinary analyses can reduce response times while increasing service effectiveness. Our value proposition is reliability, IT and institutional strength. ANCE also implements best practices regarding testing, inspection and certification from its experience with international compliance-evaluation systems.

Q: How much does ANCE’s technology innovation center in Nuevo Leon contributes to the health sector?

YM: We have experience in test laboratories and look forward to applying this experience to the health sector. ANCE is defining which products will be the first to be tested in our labs, because we expect significant growth in validations, inspections and tests in Mexico and globally. By the end of 2017 ANCE will be performing lab tests for the food and health sectors.

Q: What will be the focus for health innovations in the coming years?

AH: Innovation for hospitals is directed toward intelligent, interconnected medical devices that monitor vital signs, administer medicine or perform medical interventions. This is in line with a global trend called assisted life environment.

YM: Biotechnological products are going to be the medicine of the future. Pharmacogenetics will prevent diseases by addressing genetic deficiencies that predispose people to certain diseases. Nanotechnologies will also be an important area. Small robots will target tumorous cells and administer antitumor medicine directly instead of administering it in general and damaging both the tumor and healthy cells as some oncologic medicines do.

Q: What is ANCE’s contribution to Mexico’s health industry?

AH: We attract attention to the required regulations. Health is a dynamic sector with expected growth of 50 percent between 2015 and 2020 in the pharma segment. If COFEPRIS is saturated with requests for sanitary registrations as of 2017, it will be overwhelmed by 2020. We are in an era of disruptive innovation and new technologies and developments will require a flexible legal framework. ANCE is part of several regulation and standardization associations such as the National Commission on Normalization (CNN) and the Normalization Commission of the Industry Chambers Confederation (CONCAMIN). We try to make private initiatives more pro-active regarding the development of regulations. The private sector will be required to propose solutions and options as COFEPRIS becomes inundated.